These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2438524)

  • 21. Significant changes in HIV antigen level in the serum of patients treated with azidothymidine.
    Chaisson RE; Allain JP; Leuther M; Volberding PA
    N Engl J Med; 1986 Dec; 315(25):1610-1. PubMed ID: 3466034
    [No Abstract]   [Full Text] [Related]  

  • 22. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV antigenemia and zidovudine.
    Lefrere JJ; Courouce AM; Salmon C
    AIDS; 1988 Jun; 2(3):232. PubMed ID: 3134925
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of zidovudine on antigen levels in HIV infection.
    Glaser V
    N Y State J Med; 1988 May; 88(5):284-5. PubMed ID: 3164101
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis of a phosphonomethyl analogue of 3'-deoxy-3-fluorothymidine.
    Almer H; Classon B; Samuelsson B; Kvarnström I
    Acta Chem Scand (Cph); 1991 Aug; 45(7):766-7. PubMed ID: 1782107
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential inhibition of HIV-1 cell binding and HIV-1-induced syncytium formation by low molecular weight sulphated polysaccharides.
    Montefiori DC; Robinson WE; Modliszewski A; Rowland JM; Schuffman SS; Mitchell WM
    J Antimicrob Chemother; 1990 Mar; 25(3):313-8. PubMed ID: 1692572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmission of HIV by antigen presenting cells during T-cell activation: prevention by 3'-azido-3'-deoxythymidine.
    Lyerly HK; Cohen OJ; Weinhold KJ
    AIDS Res Hum Retroviruses; 1987; 3(1):87-94. PubMed ID: 3497654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sulfated schizophyllan as a anti-HIV agent].
    Sugawara I; Hirata A; Itoh W
    Nihon Rinsho; 1993 Sep; 51 Suppl():158-63. PubMed ID: 7505844
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro.
    Mitsuya H; Broder S
    AIDS Res Hum Retroviruses; 1988 Apr; 4(2):107-13. PubMed ID: 2835072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of synergistic response to combinations containing AZT in AZT-resistant HIV-1.
    Cox SW; Albert J; Wahlberg J; Uhlén M; Wahren B
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1229-34. PubMed ID: 1520536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy after retroviral inoculation.
    Ruprecht RM; Gama-Sosa MA; Rosas HD
    Lancet; 1988 Jan; 1(8579):239-40. PubMed ID: 2893060
    [No Abstract]   [Full Text] [Related]  

  • 32. New combinations beat HIV in vitro.
    Nurs Stand; 1993 Mar 17-23; 7(26):17. PubMed ID: 8481305
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-human immunodeficiency virus effects of dextran sulfate are strain dependent and synergistic or antagonistic when dextran sulfate is given in combination with dideoxynucleosides.
    Busso ME; Resnick L
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1991-5. PubMed ID: 2291665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in the development of antiviral therapy for HTLV-III-associated diseases.
    Yarchoan R; Broder S
    Important Adv Oncol; 1987; ():293-311. PubMed ID: 2841232
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppression of human immunodeficiency virus replication by 3'-azido-3'-deoxythymidine in various human hematopoietic cell lines in vitro: augmentation of the effect by lentinan.
    Tochikura TS; Nakashima H; Kaneko Y; Kobayashi N; Yamamoto N
    Jpn J Cancer Res; 1987 Jun; 78(6):583-9. PubMed ID: 3112074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anticoagulant activity of dextran sulphate. I. An in vitro comparison between the actions of dextran sulphate and heparin on the various stages of blood coagulation.
    FORWELL GD; INGRAM GI
    J Pharm Pharmacol; 1956 Jul; 8(7):530-45. PubMed ID: 13346452
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiviral drug development for the treatment of human immunodeficiency virus infections. An overview.
    Hirsch MS
    Am J Med; 1988 Aug; 85(2A):182-5. PubMed ID: 3044083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutropenia in an HIV-1-infected renal transplant recipient treated with zidovudine.
    Erice A; Rhame FS; Dunn DL; Chinnock B; Balfour HH
    JAMA; 1988 Jun; 259(23):3407-8. PubMed ID: 3286912
    [No Abstract]   [Full Text] [Related]  

  • 39. AZT helpful in HIV infection.
    N Z Med J; 1988 Apr; 101(844):222. PubMed ID: 3163108
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiviral drugs other than zidovudine and immunomodulating therapies in human immunodeficiency virus infection. An overview.
    Clumeck N; Hermans P
    Am J Med; 1988 Aug; 85(2A):165-72. PubMed ID: 2457313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.